-
1دورية أكاديمية
المؤلفون: Adenis, A., Blay, J.-Y., Bui-Nguyen, B., Bouché, O., Bertucci, F., Isambert, N., Bompas, E., Chaigneau, L., Domont, J., Ray-Coquard, I., Blésius, A., Van Tine, B.A., Bulusu, V.R., Dubreuil, P., Mansfield, C.D., Acin, Y., Moussy, A., Hermine, O., Le Cesne, A. *
المصدر: In Annals of Oncology September 2014 25(9):1762-1769
-
2دورية أكاديمية
المؤلفون: Reichardt, P. *, Blay, J.-Y., Gelderblom, H., Schlemmer, M., Demetri, G.D., Bui-Nguyen, B., McArthur, G.A., Yazji, S., Hsu, Y., Galetic, I., Rutkowski, P.
المصدر: In Annals of Oncology July 2012 23(7):1680-1687
-
3دورية أكاديمية
المؤلفون: Duffaud, Florence, Egerer, Gerlinde, Ferrari, Stefano, Rassam, Hisham, Boecker, Ulrike, Bui-Nguyen, B.
المصدر: In European Journal of Cancer March 2012 48(4):564-570
-
4دورية أكاديمية
المؤلفون: Bui-Nguyen, B.
المصدر: Oncologie. April 2016 18(4):199-200
-
5دورية أكاديمية
المؤلفون: van der Graaf, WT, Blay, JY, Chawla, SP, Kim, DW, Bui-Nguyen, B, Casali, PG, Schöffski, P, Aglietta, M, Staddon, AP, Beppu, Y, Le Cesne, A, Gelderblom, H, Judson, IR, Araki, N, Ouali, M, Marreaud, S, Hodge, R, Dewji, MR, Coens, C, Demetri, GD, Fletcher, CD, Dei Tos, AP, Hohenberger, P, GENNIGENS, Christine
المصدر: The Lancet, 379 (9829), 1879-1886 (2012-05-19)
مصطلحات موضوعية: Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
Relation: urn:issn:0140-6736; urn:issn:1474-547X
URL الوصول: https://orbi.uliege.be/handle/2268/186327
-
6
المؤلفون: Stéphanie Clisant, J.-Y. Blay, C. Fournier, Mathieu Molimard, Eric Yaovi Amela, Tresch-Bruneel E, Antoine Adenis, Emmanuelle Chauzit, Bui-Nguyen B, P. A. Cassier, Antoine Italiano, I.L. Ray-Coquard, Nicolas Penel
المصدر: British Journal of Cancer
مصطلحات موضوعية: Adult, Male, Cancer Research, Bone marrow transplant, Skin Neoplasms, Maximum Tolerated Dose, Cyclophosphamide, Pharmacology, gastrointestinal stromal tumour, Fixed dose, Disease-Free Survival, Piperazines, Neoplasms, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Chordoma, medicine, Humans, Molecular Targeted Therapy, Melanoma, Metronomic cyclophosphamide, Aged, Gastrointestinal Neoplasms, Aged, 80 and over, Dose-Response Relationship, Drug, business.industry, Middle Aged, medicine.disease, metronomic cyclophosphamide, Pyrimidines, Imatinib mesylate, imatinib, Oncology, Maximum tolerated dose, Administration, Metronomic, Benzamides, Clinical Study, Imatinib Mesylate, Cancer research, Feasibility Studies, Female, Liver cancer, business, medicine.drug
-
7مورد إلكتروني
-
8مورد إلكتروني
المؤلفون: Bui-Nguyen, B., Butrynski, J.E., Penel, N., Blay, J.Y., Isambert, N., Milhem, M., Kerst, J.M., Reyners, A.K., Litiere, S., Marreaud, S., Collin, F., Graaf, W.T.A. van der
المصدر: European Journal of Cancer; 1312; 1320; 0959-8049; 10; 51; ~European Journal of Cancer~1312~1320~~~0959-8049~10~51~~
-
9دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
10
المؤلفون: van der Graaf WT, Blay, Jy, Chawla, Sp, Kim, Dw, Bui Nguyen, B, Casali, Pg, Schöffski, P, Aglietta, Massimo, Staddon, Ap, Beppu, Y, Le Cesne, A, Gelderblom, H, Judson, Ir, Araki, N, Ouali, M, Marreaud, S, Hodge, R, Dewji, Mr, Coens, C, Demetri, Gd, Fletcher, Cd, Dei Tos AP, Hohenberger, P, EORTC Soft Tissue, Bone Sarcoma Group, PALETTE study group
المساهمون: Bauer, Sebastian (Beitragende*r)
المصدر: The Lancet (London), 379, 1879-86
The Lancet (London), 379, 9829, pp. 1879-86
Lancet, 379(9829), 1879-1886مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Indazoles, Adolescent, phase 3 trial, Urology, Medizin, Phases of clinical research, Antineoplastic Agents, Soft Tissue Neoplasms, Kaplan-Meier Estimate, Placebo, Disease-Free Survival, Pazopanib, Young Adult, Double-Blind Method, Translational research [ONCOL 3], medicine, Clinical endpoint, Humans, metastatic soft-tissue sarcoma, Aged, Sulfonamides, Intention-to-treat analysis, Cross-Over Studies, business.industry, Medicine (all), Soft tissue sarcoma, Hazard ratio, Sarcoma, Age-related aspects of cancer Quality of hospital and integrated care [ONCOL 2], General Medicine, Middle Aged, medicine.disease, Surgery, Pyrimidines, Treatment Outcome, Female, business, Olaratumab, medicine.drug